Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V6VQ
|
||||
| Former ID |
DIB004056
|
||||
| Drug Name |
PF-956980
|
||||
| Synonyms |
Janus kinase 3 inhibitors (inflammation); PF-956980; JAK3 inhibitors (inflammation), Pfizer; Janus kinase 3 inhibitors (inflammation), Pfizer
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543546] | ||
| Company |
Pfizer Inc
|
||||
| Canonical SMILES |
C1CCCN1C(=O)N1C[C@H](N(c2ncnc3c2cc[nH]3)C)[C@@H](CC1)C
|
||||
| Target and Pathway | |||||
| Target(s) | Tyrosine-protein kinase JAK3 | Target Info | Inhibitor | [543546] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.